We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RELY icon
1401
Remitly
RELY
$5.14B
$4.57M ﹤0.01%
219,702
+11,213
+5% +$257K
IPGP icon
1402
IPG Photonics
IPGP
$3.84B
$4.56M ﹤0.01%
72,162
-3,341
-4% -$225K
ROAD icon
1403
Construction Partners
ROAD
$6.77B
$4.56M ﹤0.01%
63,385
+3,781
+6% +$298K
COMP icon
1404
Compass
COMP
$9.66B
$4.55M ﹤0.01%
520,937
+25,005
+5% +$198K
RYTM icon
1405
Rhythm Pharmaceuticals
RYTM
$7.96B
$4.54M ﹤0.01%
85,719
+2,988
+4% +$166K
DV icon
1406
DoubleVerify
DV
$2.03B
$4.53M ﹤0.01%
338,892
-5,675
-2% -$105K
INSW icon
1407
International Seaways
INSW
$4.57B
$4.53M ﹤0.01%
136,422
+16,519
+14% +$605K
RDY icon
1408
Dr. Reddy's Laboratories
RDY
$10.2B
$4.53M ﹤0.01%
343,289
-86,773
-20% -$1.2M
QDEL icon
1409
QuidelOrtho
QDEL
$838M
$4.51M ﹤0.01%
129,025
+770
+0.6% +$31.4K
HAYW icon
1410
Hayward Holdings
HAYW
$3.36B
$4.5M ﹤0.01%
323,612
-7,301
-2% -$106K
EPC icon
1411
Edgewell Personal Care
EPC
$1.31B
$4.5M ﹤0.01%
144,095
-4,654
-3% -$146K
TNC icon
1412
Tennant Co
TNC
$1.26B
$4.49M ﹤0.01%
56,312
-591
-1% -$50K
PLUS icon
1413
ePlus
PLUS
$2.34B
$4.49M ﹤0.01%
73,541
-1,674
-2% -$118K
NWBI icon
1414
Northwest Bancshares
NWBI
$2.28B
$4.49M ﹤0.01%
373,386
-22,266
-6% -$282K
AKRO
1415
DELISTED
Akero Therapeutics
AKRO
$4.48M ﹤0.01%
110,687
+5,001
+5% +$212K
SPNT icon
1416
SiriusPoint
SPNT
$2.68B
$4.46M ﹤0.01%
257,883
-17,668
-6% -$263K
MIR icon
1417
Mirion Technologies
MIR
$3.91B
$4.46M ﹤0.01%
307,422
-11,045
-3% -$174K
CRNX icon
1418
Crinetics Pharmaceuticals
CRNX
$8.92B
$4.43M ﹤0.01%
131,950
+7,872
+6% +$294K
NVO
1419
Novo Nordisk
NVO
$209B
$4.41M ﹤0.01%
63,539
+5,898
+10% +$487K
ARWR icon
1420
Arrowhead Research
ARWR
$12.4B
$4.41M ﹤0.01%
345,979
-34,365
-9% -$625K
STNE icon
1421
StoneCo
STNE
$2.58B
$4.4M ﹤0.01%
419,883
-20,639
-5% -$194K
CUBI icon
1422
Customers Bancorp
CUBI
$2.77B
$4.4M ﹤0.01%
87,638
-3,810
-4% -$200K
ATMU icon
1423
Atmus Filtration Technologies
ATMU
$4.18B
$4.38M ﹤0.01%
119,298
+4,122
+4% +$163K
NBHC icon
1424
National Bank Holdings
NBHC
$1.9B
$4.37M ﹤0.01%
114,208
-4,764
-4% -$198K
VYX icon
1425
NCR Voyix
VYX
$1.14B
$4.36M ﹤0.01%
447,225
-8,581
-2% -$101K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.